Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × Atorvastatin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Atherosclerosis 1

Interventions

Nivolumab 2 Melphalan 2 Interleukin-2 2 trametinib 1 toripalimab 1 sulforaphane 1 secukinumab 1 relatlimab 1 pembrolizumab 1 encorafenib 1 binimetinib 1 anlotinib 1 Toll-Like Receptor 1 1 Therapeutics 1 Standard of Care 1 Specimen Handling 1 Rehabilitation 1 Ipilimumab 1 Injections 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 Doxorubicin 1 Atorvastatin 1 Afatinib 1 3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06785974 2025-01-22

SPIRAL

Erasmus Medical Center

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡